Diagnostic and Biotech

Epigenetics Market by Product [Enzymes (DNA Ligases, DNA Polymerases, Other DNA-modifying Enzymes), Kits & Assays (Bisulfite Conversion Kits, Chip-Seq Kits, Deep Sequencing Kits, Methyltransferase Assays, Histone Assays, Immunoprecipitation Kits), Instruments (Mass Spectrometers, Next-generation Sequencers, qPCRs, and Sonicators), and Reagents (Antibodies, Buffers, Histones, Magnetic Beads, Primers, and Other Epigenetics Reagents)], Application (Oncology and Non-oncology Diseases, Developmental Biology, Drug Discovery, and Others), and End User [Academic & Research Institutes, Pharmaceutical Companies, Biotechnology Companies, and Contract Research Organizations (CROs)] - Global Opportunity Analysis and Industry Forecast, 2017-2023

  • ALL1227774
  • 185 Pages
  • May 2017
  • Diagnostic and Biotech

Epigenetics is a stream of genetics that involves the study of cellular and physiological trait variations initiated by external or ecological aspects, which turn genes on and off and affect the cellular ability to read genes without being affected by changes in the genotype Epigenetics results into changes in the organisms’ phenotype rather than the genotype, wherein the underlying DNA or RNA sequence remains unchanged. The global epigenetics market accounted for $555 million in 2016, and is estimated to reach at $1,321 million by 2023, registering a CAGR of 13.1% from 2017 to 2023.

Epigenetic alterations are essential for development; they are dynamic and change with respect to the environmental stimuli. However, these changes can also be stable and could be passed on from one generation to another. Biology and genetic expressions of most organisms are affected by epigenetics, thereby making it one of the most crucial fields of developmental genetics and molecular biology.

High incidence of cancer; increase in R&D activities; surge in investments funding, rise in epigenetic applications for non-oncology diseases; and growth in partnership between academic, pharmaceutical, and biotechnology companies cumulatively supplement the growth of the global epigenetics market. However, high cost of instruments and lack of trained professionals impede the growth of this market. Furthermore, untapped potential of emerging markets provides lucrative opportunities to the market players.

The epigenetics market is segmented based on product, application, end user, and geography. Based on product, it is divided into enzymes, kits & assays, instruments, and reagents. Enzymes are further classified into DNA ligases, DNA polymerases, other DNA-modifying enzymes, acetylases, methyltransferases, other protein-modifying enzymes, reverse transcriptase, RNA ligases, and other RNA-modifying enzymes. Kits & assays are further subdivided into bisulfite conversion kits, chip-seq kits, deep sequencing kits, methyltransferase assays, histone assays, immunoprecipitation kits & other epigenetic kits. Based on instruments, the market is further sub segmented into mass spectrometers, next-generation sequencers, qPCRs, and sonicators & other instruments. Reagents are further divided into antibodies, buffers, histones, magnetic beads, primers, and other epigenetics reagents.

On the basis application, the market is classified into oncology and non-oncology. Oncology is further sub segmented into solid tumors & liquid tumors. Non-oncology applications include inflammatory diseases, metabolic diseases, infectious diseases, cardiovascular diseases, developmental biology, drug discovery, and other applications. On the basis of end user, the market is classified into academic & research institutes, pharmaceutical companies, biotechnology companies, and contract research organizations (CROs). Geographically, it is analyzed based on four regions, namely, North America, Europe, Asia-Pacific, and LAMEA.


  • The study provides an in-depth analysis of the global epigenetics market and the current trends and future estimations to elucidate the imminent investment pockets.
  • It presents a quantitative analysis of the market from 2016 to 2023 to enable stakeholders to capitalize on the prevailing market opportunities.
  • Extensive analysis of the market based on application assists to understand the trends in the industry.
  • Key market players and their strategies are thoroughly analyzed to understand the competitive outlook of the market.


  • Abcam plc.
  • Illumina
  • Epizyme, Inc.
  • New England Biolabs, Inc.
  • Merck & Co.,
  • Thermo Fisher Scientific, Inc.
  • Active Motif,
  • Diagenode, Inc.
  • Zymo Research Corporation


By Product

  • Enzymes
    • DNA Ligases
    • DNA Polymerases
    • Other DNA-modifying Enzymes
    • Acetylases
    • Methyltransferases
    • Other Protein-modifying Enzymes
    • Reverse Transcriptase
    • RNA Ligases
    • Other RNA-modifying Enzymes
  • Kits & Assays
    • Bisulfite Conversion Kits
    • Chip-seq Kits
    • Deep Sequencing Kits
    • Methyltransferase Assays
    • Histone Assays
    • Immunoprecipitation Kits
    • Other Epigenetic Kits
  • Instruments
    • Mass Spectrometers
    • Next-generation Sequencers
    • qPCRs
    • Sonicators
    • Other Instruments
  • Reagents
    • Antibodies
    • Buffers
    • Histones
    • Magnetic Beads
    • Primers
    • Other Epigenetics Reagents

By Application

  • Oncology
    • Solid Tumors
    • Liquid Tumors
  • Non-oncology
    • Inflammatory Diseases
    • Metabolic Diseases
    • Infectious Diseases
    • Cardiovascular Diseases
    • Developmental Biology
    • Drug Discovery
    • Others

By End User

  • Academic & Research Institutes
  • Pharmaceutical Companies
  • Biotechnology Companies
  • Contract Research Organizations (CROs)

By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • South Korea
    • Taiwan
    • Rest of Asia-Pacific
    • Brazil
    • Turkey
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

The other players in the value chain include (profiles not included in the report)

  • Domainex
  • CellCentric Ltd.
  • Chroma Therapeutics Ltd.
  • Eisai Co. Ltd.
  • Novartis International AG
  • Oncolys Biopharma Inc.
  • Syndax Pharmaceuticals, Inc.
  • Valirx plc.
Please Select Format

Enquiry About Report

Need More Information

Contact us
+ 1-800-910-6452
+91 20 66346066
--- or ---



European NGS Services Market - Opportunities and Forecasts, 2015 - 2020

Next Generation Sequencing (NGS) services, also known as high-throughput sequencing, is term used to describe sequencing technologies, such as Illumina sequencing, Roche 454 sequencing, and SOLiD sequencing. These technologies enable ...

April 2018| $3390 | Pre Book Price:$2967

World Surface Analysis Market - Opportunities and Forecasts, 2014 - 2020

Surface analysis is a technique that provides a medium to correlate performance with thin film conformation. The analysis is used in the discovery of new materials and to enhance the ...

April 2018| $5370 | Pre Book Price:$4699

World Electrophoresis Market - Opportunities and Forecasts, 2015 - 2020

Electrophoresis is a technique used for separation of proteins and nucleic acids. This technique is primarily used for RNA and DNA analysis. It is also used in biochemistry for separation ...

April 2018| $5370 | Pre Book Price:$4699

World Oxidative Stress Assay Market - Opportunities and Forecasts, 2015 - 2020

Oxidative stress assay is used to determine level of oxidative stress markers and reagents in cells. Applications of oxidative stress assay are research laboratories and bioproduction. Assays detect generalized oxidative ...

April 2018| $5370 | Pre Book Price:$4699

European Microscopy Market - Opportunities and Forecasts, 2015 - 2020

Microscopy is a field of science in which objects are not visible to bare eye can be viewed under microscope. It is used to observe macromolecules and macromolecular complexes at ...

April 2018| $3390 | Pre Book Price:$2967

World Immunoassay Market - Opportunities and Forecasts, 2015 - 2020

Immunoassay is a test conducted to determine concentration of macromolecule in a solution using antibody or immunoglobulin. The macromolecule detected is known as analyte. Immunoassay is used to measure quantity ...

April 2018| $5370 | Pre Book Price:$4699

2018 © Copyright Big Market Research

View Pricing >>